Plain-English translation of NCT06538857 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This is an early-stage trial testing , a special membrane implant that doctors place in the body during pancreatic cancer surgery. The trial compares two groups: patients who receive standard surgery plus the implant, and patients who receive standard surgery alone. Researchers want to see if this implant is safe and whether it helps reduce the chance of cancer returning in the same area.
Pancreatic cancer often comes back in the area where the tumor was removed, even after surgery. This trial is exploring whether the new implant can help prevent local recurrence and improve outcomes for patients with resectable pancreatic cancer.
You likely qualify if…
You likely don't qualify if…
You will first go through a screening period of up to 35 days to confirm you are eligible. Then you will have surgery to remove the pancreatic cancer — and depending on which group you're assigned to, your surgeon may also place the new implant. After surgery, you will come back for follow-up visits and blood tests: several blood draws over the first 6 weeks, then check-ins at 1 year and 3 years after surgery to see how you are doing and whether the treatment helped prevent cancer recurrence.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Spain